Upcoming Xtalks Webinar: "Think Enrolling Your NASH Trial Will Be Easy? Think Again"

09:00 EDT 2 May 2019 | PR Web

Not only is nonalcoholic steatohepatitis (NASH) and its precursor, nonalcoholic fatty liver disease (NAFLD), virtually unheard of among the most high-risk patient population, it’s difficult to diagnose and it disproportionately affects those who are already marginalized. This poses a dramatic problem for clinical trial enrollment, since the next five years will see more than 60 sponsors attempt to randomize nearly 30,000 NASH patients into clinical trials.

TORONTO (PRWEB) May 02, 2019

The prevalence of NASH is estimated to be up to 25 percent of the population in the developed world, yet fewer than two percent of people have even heard of it. This will become a monumental challenge for clinical trial enrollment. Moreover, awareness barely increases (up to six percent) among those most at risk for developing the chronic, potentially fatal condition. Finding patients to randomize in to a clinical trial will require a multi-pronged approach: deep understanding of the patient journey, a full commitment to patient and community engagement, targeted, empathetic recruitment campaign messaging and smart, data-driven site support.

In a live webinar upcoming on Wednesday, May 22, 2019 at 1pm EDT, participants will learn:

  • Results of a proprietary insights study conducted with this at-risk patient population
  • How low awareness among patients and healthcare professionals impacts clinical trial enrollment
  • Patient journey insights to inform education and engagement strategies
  • Campaign messaging strategies designed to maximize referrals
  • Analytic-driven, site-level recruitment solutions

The guest speakers who will also be on hand for a Q&A with the audience, include:

  • Pamela Landau, Senior Vice President Patient Recruitment, Continuum Clinical
  • Bob Klein, Chief Insights and Experience Officer, Continuum Clinical
  • Wayne Eskridge, CEO, Fatty Liver Foundation
  • Qin Ye, MD, MS, Associate Principal, ZS Associates

For more information or to register for this event, visit Think Enrolling Your NASH Trial Will Be Easy? Think Again.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

For the original version on PRWeb visit:


More From BioPortfolio on "Upcoming Xtalks Webinar: "Think Enrolling Your NASH Trial Will Be Easy? Think Again""

Quick Search

Relevant Topic

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...